These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7448590)

  • 1. [Clinical followup of the uricosuric drug--benzbromaron (author's transl)].
    Dzúrik R; Fedelesová V; Danĕková H; Hlavatá E
    Bratisl Lek Listy; 1980 Nov; 74(5):547-54. PubMed ID: 7448590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F; Berg G
    Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F; Neuwirth R; Berg G
    Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of benzbromarone: a new uricosuric drug.
    Sorensen LB; Levinson DJ
    Arthritis Rheum; 1976; 19(2):183-90. PubMed ID: 1259799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
    Mertz DP
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
    [No Abstract]   [Full Text] [Related]  

  • 8. [The uricosuric effect of benzbromaron and probenecid under fasting conditions (author's transl)].
    Schulz E; Schräpler P; Kleinschmidt A
    Med Klin; 1978 Feb; 73(7):240-6. PubMed ID: 628361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May; 97(17):835-6. PubMed ID: 437646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K; Trnavský K
    Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzbromarone as a long-term uricosuric agent.
    Bluestone R; Klinenberg J; Lee IK
    Adv Exp Med Biol; 1980; 122A():283-6. PubMed ID: 6999849
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of uric acid concentration in serum and saliva of healthy or hyperuricemic subjects].
    Schermann JM; Meunier J; Ricordel I; Masbernard A; Giudicelli C
    Ann Biol Clin (Paris); 1977; 35(6):467-72. PubMed ID: 615505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzbromarone therapy in hyperuricaemia.
    Scott WA
    J Int Med Res; 1981; 9(1):82-7. PubMed ID: 7009259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerance of a new benzbromarone preparation].
    Jelke K; Neubauer M; Krause G; Jüttner A; Angar T; Grosse-Kielisch C; Bach GL
    Med Welt; 1980 May; 31(21):821-2. PubMed ID: 7392938
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacotherapeutical action on arteriosclerotic vascular diseases with benzarone (author's transl)].
    Mörl H; Diehm C; Zimmermann R; Schöffel G; Walter E
    MMW Munch Med Wochenschr; 1980 Feb; 122(8):277-80. PubMed ID: 6767967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect on uric acid and other laboratory parameters. A long-term study].
    Dorn M
    ZFA (Stuttgart); 1982 Feb; 58(5):296-300. PubMed ID: 7043937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
    Schräpler P; Schulz E
    Med Welt; 1976 Mar; 27(12):575-81. PubMed ID: 1263801
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
    Bach D; Hesse A; Strenge A; Vahlensieck W
    Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.